{"anticipatedPostingDate":"2027-12","denomUnitsSelected":"Participants","description":"BRAF V600 status from ctDNA was classified as follows; measurable: participants with detectable ctDNA had measurable BRAF V600 tumor biomarker alterations and not measurable: participants with detectable ctDNA did not have measurable BRAF V600 biomarker alterations or overall ctDNA was not detectable. The number of participants as per their BRAF V600 status from ctDNA (measurable and not measurable) have been reported in this outcome measure.","reportingStatus":"NOT_POSTED","timeFrame":"Through end of the study","title":"Cohort 3: Number of Participants According to BRAF V600 Status From ctDNA","type":"SECONDARY"}